Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
20.47
-0.22 (-1.06%)
At close: Apr 6, 2026, 4:00 PM EDT
20.07
-0.40 (-1.95%)
After-hours: Apr 6, 2026, 6:27 PM EDT
Neurogene Market Cap
Neurogene has a market cap or net worth of $318.81 million as of April 6, 2026. Its market cap has increased by 39.18% in one year.
Market Cap
318.81M
Enterprise Value
59.68M
1-Year Change
39.18%
Ranking
Category
Stock Price
$20.47
Market Cap Chart
Since December 19, 2023, Neurogene's market cap has increased from $193.64M to $318.81M, an increase of 64.64%. That is a compound annual growth rate of 24.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 322.23M | 0.98% |
| Dec 31, 2025 | 319.09M | -6.03% |
| Dec 31, 2024 | 339.58M | 36.64% |
| Dec 29, 2023 | 248.52M | 28.34% |
| Dec 19, 2023 | 193.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Puma Biotechnology | 342.40M |
| Rezolute | 332.91M |
| Climb Bio | 330.55M |
| Palisade Bio | 328.15M |
| Opus Genetics | 323.73M |
| Surrozen | 321.91M |
| Greenwich LifeSciences | 318.03M |
| Prelude Therapeutics | 316.11M |